MiR-128-1-5p inhibits cell proliferation and induces cell apoptosis via targeting PRKCQ in colorectal cancer

References

• Kanth P, Inadomi JM. Screening and prevention of colorectal cancer. BMJ. 2021;374:n1855. doi:10.1136/bmj.n1855.
   PubMed Web of Science ®Google Scholar
• Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: gLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394–10. doi:10.3322/caac.21492.
   PubMed Web of Science ®Google Scholar
• Siegel RL, Miller KD, Goding Sauer A, Fedewa SA, Butterly LF, Anderson JC, Cercek A, Smith RA, Jemal A. Colorectal cancer statistics, 2020. CA Cancer J Clin. 2020;70(3):145–164. doi:10.3322/caac.21601.
   PubMed Web of Science ®Google Scholar
• Rodel C, Liersch T, Becker H, Fietkau R, Hohenberger W, Hothorn T, Graeven U, Arnold D, Lang-Welzenbach M, Raab H-R, et al. Preoperative chemoradiotherapy and postoperative chemotherapy with fluorouracil and oxaliplatin versus fluorouracil alone in locally advanced rectal cancer: initial results of the German CAO/ARO/AIO-04 randomised phase 3 trial. Lancet Oncol. 2012;13(7):679–687. doi:10.1016/S1470-2045(12)70187-0.
   PubMed Web of Science ®Google Scholar
• Wang Y, Wang L, Chen C, Chu X. New insights into the regulatory role of microRNA in tumor angiogenesis and clinical implications. Mol Cancer. 2018;17(1):22. doi:10.1186/s12943-018-0766-4.
   PubMedGoogle Scholar
• Jung G, Hernández-Illán E, Moreira L, Balaguer F, Goel A. Epigenetics of colorectal cancer: biomarker and therapeutic potential. Nat Rev Gastro Hepat. 2020;17(2):111–130. doi:10.1038/s41575-019-0230-y.
   PubMed Web of Science ®Google Scholar
• Ali Syeda Z, Langden SSS, Munkhzul C, Lee M, Song SJ. Regulatory mechanism of MicroRNA expression in Cancer. IJMS. 2020;21(5):21. doi:10.3390/ijms21051723.
   Google Scholar
• Bartel DP. MicroRNAs: target recognition and regulatory functions. Cell. 2009;136(2):215–233. doi:10.1016/j.cell.2009.01.002.
   PubMed Web of Science ®Google Scholar
• Guo Y, Guo Y, Chen C, Fan D, Wu X, Zhao L, Shao B, Sun Z, Ji Z. Circ3823 contributes to growth, metastasis and angiogenesis of colorectal cancer: involvement of miR-30c-5p/TCF7 axis. Mol Cancer. 2021;20(1):93. doi:10.1186/s12943-021-01372-0.
   PubMed Web of Science ®Google Scholar
• Zhu Q, Zhang Q, Gu M, Zhang K, Xia T, Zhang S, Chen W, Yin H, Yao H, Fan Y, et al. Mir106A-5p upregulation suppresses autophagy and accelerates malignant phenotype in nasopharyngeal carcinoma. Autophagy. 2021;17(7):1667–1683. doi:10.1080/15548627.2020.1781368.
   PubMed Web of Science ®Google Scholar
• Cao MQ, You AB, Zhu XD, Zhang W, Zhang YY, Zhang SZ, Zhang K-W, Cai H, Shi W-K, Li X-L, et al. MiR-182-5p promotes hepatocellular carcinoma progression by repressing FOXO3a. J Hematol Oncol. 2018;11(1):12. doi:10.1186/s13045-018-0555-y.
   PubMed Web of Science ®Google Scholar
• Cao XZ, Bin H, Zang ZN. MiR-128 suppresses the growth of thyroid carcinoma by negatively regulating SPHK1. Biomed Pharmacother. 2019;109:1960–1966. doi:10.1016/j.biopha.2018.08.052.
   PubMed Web of Science ®Google Scholar
• Xiao M, Lou C, Xiao H, Yang Y, Cai X, Li C, Jia S, Huang Y. MiR-128 regulation of glucose metabolism and cell proliferation in triple-negative breast cancer. Br J Surg. 2018;105(1):75–85. doi:10.1002/bjs.10646.
   PubMed Web of Science ®Google Scholar
• Cai J, Fang L, Huang Y, Li R, Xu X, Hu Z, Zhang L, Yang Y, Zhu X, Zhang H, et al. Simultaneous overactivation of Wnt/β-catenin and TGFβ signalling by miR-128-3p confers chemoresistance-associated metastasis in NSCLC. Nat Commun. 2017;8(1):15870. doi:10.1038/ncomms15870.
   PubMed Web of Science ®Google Scholar
• Liu T, Zhang X, Du L, Wang Y, Liu X, Tian H, Wang L, Li P, Zhao Y, Duan W, et al. RETRACTED ARTICLE: exosome-transmitted miR-128-3p increase chemosensitivity of oxaliplatin-resistant colorectal cancer. Mol Cancer. 2019;18(1):43. doi:10.1186/s12943-019-0981-7.
   PubMedGoogle Scholar
• Nicolle A, Zhang Y, Belguise K. The emerging function of PKCtheta in Cancer. Biomolecules. 2021;11(2):11. doi:10.3390/biom11020221.
   Web of Science ®Google Scholar
• Byerly JH, Port ER, Irie HY. PRKCQ inhibition enhances chemosensitivity of triple-negative breast cancer by regulating Bim. Breast Cancer Res. 2020;22(1):72. doi:10.1186/s13058-020-01302-w.
   PubMed Web of Science ®Google Scholar
• Siegel RL, Miller KD, Fuchs HE, Jemal A. Cancer statistics, 2022. CA Cancer J Clin. 2022;72(1):7–33. doi:10.3322/caac.21708.
   PubMed Web of Science ®Google Scholar
• Dekker E, Tanis PJ, Vleugels JLA, Kasi PM, Wallace MB. Colorectal cancer. Lancet. 2019;394(10207):1467–1480. doi:10.1016/S0140-6736(19)32319-0.
   PubMed Web of Science ®Google Scholar
• Stein A, Atanackovic D, Bokemeyer C. Current standards and new trends in the primary treatment of colorectal cancer. Eur J Cancer. 2011;47(Suppl 3):S312–4. doi:10.1016/S0959-8049(11)70183-6.
   PubMedGoogle Scholar
• Loupakis F, Cremolini C, Masi G, Lonardi S, Zagonel V, Salvatore L, Cortesi E, Tomasello G, Ronzoni M, Spadi R, et al. Initial therapy with FOLFOXIRI and bevacizumab for metastatic colorectal cancer. N Engl J Med. 2014;371(17):1609–1618. doi:10.1056/NEJMoa1403108.
   PubMed Web of Science ®Google Scholar
• Zhang N, Hu X, Du Y, Du J. The role of miRnas in colorectal cancer progression and chemoradiotherapy. Biomed Pharmacother. 2021;134:111099. doi:10.1016/j.biopha.2020.111099.
   PubMed Web of Science ®Google Scholar
• Saberinia A, Alinezhad A, Jafari F, Soltany S, Akhavan Sigari R. Oncogenic miRnas and target therapies in colorectal cancer. Clin Chim Acta. 2020;508:77–91. doi:10.1016/j.cca.2020.05.012.
   PubMed Web of Science ®Google Scholar
• Balacescu O, Sur D, Cainap C, Visan S, Cruceriu D, Manzat-Saplacan R, Muresan M-S, Balacescu L, Lisencu C, Irimie A, et al. The Impact of miRNA in colorectal cancer progression and its liver metastases. Int J Mol Sci. 2018;19(12):3711. doi:10.3390/ijms19123711.
   PubMed Web of Science ®Google Scholar
• Lin Y, Wu Z. MicroRNA-128 inhibits proliferation and invasion of glioma cells by targeting COX-2. Gene. 2018;658:63–69. doi:10.1016/j.gene.2018.03.020.
   PubMed Web of Science ®Google Scholar
• Chang A-C, Lien M-Y, Tsai M-H, Hua C-H, Tang C-H. WISP-1 Promotes epithelial-mesenchymal transition in oral squamous cell carcinoma cells via the miR-153-3p/Snail axis. Cancers. 2019;11(12):11. doi:10.3390/cancers11121903.
   Web of Science ®Google Scholar
• Zafar A, Wu F, Hardy K, Li J, Tu WJ, McCuaig R, Harris J, Khanna KK, Attema J, Gregory PA, et al. Chromatinized protein kinase C-θ directly regulates inducible genes in epithelial to mesenchymal transition and breast cancer stem cells. Mol Cell Biol. 2014;34(16):2961–2980. doi:10.1128/MCB.01693-13.
   PubMed Web of Science ®Google Scholar
• Belguise K, Milord S, Galtier F, Moquet-Torcy G, Piechaczyk M, Chalbos D. The PKCθ pathway participates in the aberrant accumulation of Fra-1 protein in invasive ER-negative breast cancer cells. Oncogene. 2012;31(47):4889–4897. doi:10.1038/onc.2011.659.
   PubMed Web of Science ®Google Scholar
• Hage-Sleiman R, Hamze AB, Reslan L, Kobeissy H, Dbaibo G. The novel PKCtheta from Benchtop to clinic. J Immunol Res. 2015;2015:348798. doi:10.1155/2015/348798.
   PubMed Web of Science ®Google Scholar
• Byerly J, Halstead-Nussloch G, Ito K, Katsyv I, Irie HY. PRKCQ promotes oncogenic growth and anoikis resistance of a subset of triple-negative breast cancer cells. Breast Cancer Res. 2016;18(1):95. doi:10.1186/s13058-016-0749-6.
   PubMedGoogle Scholar
• Li R, Qu H, Wang S, Chater JM, Wang X, Cui Y, Yu L, Zhou R, Jia Q, Traband R, et al. CancerMIRNome: an interactive analysis and visualization database for miRnome profiles of human cancer. Nucleic Acids Research. 2022;50(D1):D1139–D1146. doi:10.1093/nar/gkab784.
   PubMed Web of Science ®Google Scholar
• Li X, Liang L, Huang L, Ma X, Li D, Cai S. High expression of protein phosphatase 4 is associated with the aggressive malignant behavior of colorectal carcinoma. Mol Cancer. 2015;14(1):95. doi:10.1186/s12943-015-0356-7.
   PubMed Web of Science ®Google Scholar